STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Mycronic (STO:MYCR) Second quarter April-June 2015 · Order intake was SEK 311 (281) million · Net sales were SEK 285 (238) million · EBIT was SEK 1 (6) million · Earnings per share were SEK 0.01 (0.03) Interim period January-June 2015 · Order intake was SEK 782 (568) million · Net sales were SEK 589 (481) million · EBIT was SEK 27 (9) million · Earnings per share were SEK 0.20 (0.04) Outlook The Board’s assessment remains that sales in 2015 will be i
| < Prev | Next > |
|---|
